ID

41819

Descripción

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS); ODM derived from: https://clinicaltrials.gov/show/NCT00986960

Link

https://clinicaltrials.gov/show/NCT00986960

Palabras clave

Versiones (3)
  1. 21/1/21 21/1/21 - Ahmed Rafee, MD
  2. 22/1/21 22/1/21 - Ahmed Rafee, MD
  3. 22/1/21 22/1/21 - Sarah Riepenhausen
Titular de derechos de autor

University at Buffalo

Subido en

22 de enero de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Sclerosis NCT00986960

Inglés

Eligibility Multiple Sclerosis NCT00986960

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient diagnosed with ms according to mcdonald criteria
Descripción

patient diagnosed with ms according to mcdonald criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0679228
age 18-65
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
have a rr disease course
Descripción

have a rr disease course

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3808177
UMLS CUI [1,2]
C0026769
have edss scores 0-5.5
Descripción

have edss scores 0-5.5

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451246
have a disease duration <20 years
Descripción

have a disease duration <20 years

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0872146
UMLS CUI [1,2]
C0026769
sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months
Descripción

sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0254119
UMLS CUI [1,2]
C0021492
UMLS CUI [1,3]
C2984009
UMLS CUI [1,4]
C0521982
UMLS CUI [1,5]
C0026769
UMLS CUI [1,6]
C0444921
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C0026769
UMLS CUI [2,3]
C0332185
UMLS CUI [2,4]
C1301725
UMLS CUI [3,1]
C1333400
UMLS CUI [3,2]
C0449788
signed informed consent
Descripción

signed informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
normal kidney functioning (creatinine clearance >59)
Descripción

normal kidney functioning (creatinine clearance >59)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
none of the exclusion criteria
Descripción

none of the exclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0444868
UMLS CUI [1,3]
C0332197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of relapse or steroid treatment within 60 days prior to study enrollment
Descripción

presence of relapse or steroid treatment within 60 days prior to study enrollment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0035020
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C0149783
UMLS CUI [2,2]
C0332185
presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment
Descripción

presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1997641
UMLS CUI [1,2]
C0332185
presence of optic neuritis within less than 6 months prior to study enrollment
Descripción

presence of optic neuritis within less than 6 months prior to study enrollment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0029134
UMLS CUI [1,2]
C0332185
diagnosis of osteoporosis (t score ≥2.5 sd)
Descripción

diagnosis of osteoporosis (t score ≥2.5 sd)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029456
UMLS CUI [2]
C3854607
women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.
Descripción

women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0558080
abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes
Descripción

abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0178913
UMLS CUI [1,2]
C0022885
UMLS CUI [1,3]
C0205161
UMLS CUI [1,4]
C1710032
UMLS CUI [2,1]
C0744837
UMLS CUI [2,2]
C0205161
UMLS CUI [3,1]
C0850489
UMLS CUI [3,2]
C0205161
UMLS CUI [4,1]
C0201836
UMLS CUI [4,2]
C0205161
UMLS CUI [5,1]
C0201899
UMLS CUI [5,2]
C0205161
UMLS CUI [6,1]
C0583513
UMLS CUI [6,2]
C0205161
UMLS CUI [7]
C0011849
history of depression while on ifnβ-1a i.m.
Descripción

history of depression while on ifnβ-1a i.m.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205156
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C0011581
UMLS CUI [1,4]
C0041755
UMLS CUI [1,5]
C0254119
Volver a la parte superior de la página

Similar models

Eligibility Multiple Sclerosis NCT00986960

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
patient diagnosed with ms according to mcdonald criteria
Item
patient diagnosed with ms according to mcdonald criteria
boolean
C0026769 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
Age
Item
age 18-65
boolean
C0001779 (UMLS CUI [1])
have a rr disease course
Item
have a rr disease course
boolean
C3808177 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
have edss scores 0-5.5
Item
have edss scores 0-5.5
boolean
C0451246 (UMLS CUI [1])
have a disease duration <20 years
Item
have a disease duration <20 years
boolean
C0872146 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months
Item
sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months
boolean
C0254119 (UMLS CUI [1,1])
C0021492 (UMLS CUI [1,2])
C2984009 (UMLS CUI [1,3])
C0521982 (UMLS CUI [1,4])
C0026769 (UMLS CUI [1,5])
C0444921 (UMLS CUI [1,6])
C0035020 (UMLS CUI [2,1])
C0026769 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
C1301725 (UMLS CUI [2,4])
C1333400 (UMLS CUI [3,1])
C0449788 (UMLS CUI [3,2])
signed informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
normal kidney functioning (creatinine clearance >59)
Item
normal kidney functioning (creatinine clearance >59)
boolean
C0373595 (UMLS CUI [1])
none of the exclusion criteria
Item
none of the exclusion criteria
boolean
C0680251 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
presence of relapse or steroid treatment within 60 days prior to study enrollment
Item
presence of relapse or steroid treatment within 60 days prior to study enrollment
boolean
C0026769 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment
Item
presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment
boolean
C1997641 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
presence of optic neuritis within less than 6 months prior to study enrollment
Item
presence of optic neuritis within less than 6 months prior to study enrollment
boolean
C0029134 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
diagnosis of osteoporosis (t score ≥2.5 sd)
Item
diagnosis of osteoporosis (t score ≥2.5 sd)
boolean
C0029456 (UMLS CUI [1])
C3854607 (UMLS CUI [2])
women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.
Item
women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes
Item
abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes
boolean
C0178913 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0205161 (UMLS CUI [1,3])
C1710032 (UMLS CUI [1,4])
C0744837 (UMLS CUI [2,1])
C0205161 (UMLS CUI [2,2])
C0850489 (UMLS CUI [3,1])
C0205161 (UMLS CUI [3,2])
C0201836 (UMLS CUI [4,1])
C0205161 (UMLS CUI [4,2])
C0201899 (UMLS CUI [5,1])
C0205161 (UMLS CUI [5,2])
C0583513 (UMLS CUI [6,1])
C0205161 (UMLS CUI [6,2])
C0011849 (UMLS CUI [7])
history of depression while on ifnβ-1a i.m.
Item
history of depression while on ifnβ-1a i.m.
boolean
C0205156 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0011581 (UMLS CUI [1,3])
C0041755 (UMLS CUI [1,4])
C0254119 (UMLS CUI [1,5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial